Kura Oncology, Inc. (KURA) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Kura Oncology, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -3.27x | -4.31x | -6.90x | -6.12x | -7.12x | -19.34x |
| P/B Ratio | 5.23x | 1.81x | 2.65x | 1.98x | 1.83x | 2.84x |
| P/S Ratio | 13.50x | 13.93x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 99.9% | 100.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | -449.9% | -358.5% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | -412.9% | -322.9% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | -408.7% | -314.6% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 6.06x | 9.46x | 12.26x | 18.56x | 23.26x | 24.49x |
| Quick Ratio | 6.05x | 9.46x | 12.26x | 18.56x | 23.26x | 24.49x |
| Leverage | ||||||
| Debt/Equity | 0.12x | 0.04x | 0.04x | 0.03x | 0.01x | 0.02x |
YoY = year-over-year change. Source: FMP..